Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Should You Buy?

Shares of Elekta AB (OTCMKTS:EKTAY) saw an uptick in trading volume on Tuesday . 8,635 shares changed hands during mid-day trading, an increase of 250% from the previous session’s volume of 2,464 shares.The stock last traded at $5.0410 and had previously closed at $5.00.

Analyst Ratings Changes

Separately, Zacks Research lowered Elekta from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Sell rating, According to MarketBeat.com, Elekta has an average rating of “Sell”.

Elekta Stock Performance

The firm has a market capitalization of $1.96 billion, a price-to-earnings ratio of -33.19 and a beta of 1.01. The stock’s fifty day moving average is $5.71 and its two-hundred day moving average is $6.01. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.47.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. The firm had revenue of $521.00 million for the quarter. On average, analysts predict that Elekta AB will post 0.43 earnings per share for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.